1 asset in Barth Syndrome
Therapeutic assets addressing Barth Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Elamipretide Trihydrochloride Barth Syndrome | Stealth BioTherapeutics Inc. | P4 | BBB (72) |